Abstract
Soft tissue vascular anomalies may be composed of arterial, venous, and/or lymphatic elements, and diagnosed prenatally or later in childhood or adulthood. They are divided into categories of vascular malformations and vascular tumors. Vascular malformations are further divided into low-flow and fast-flow lesions. A low-flow lesion is most common, with a prevalence of 70%. Vascular tumors may behave in a benign, locally aggressive, borderline, or malignant manner. Infantile hemangioma is a vascular tumor that presents in the neonatal period and then regresses. The presence or multiple skin lesions in an infant can signal underlying visceral vascular anomalies, and complex anomalies may be associated with overgrowth syndromes. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision process support the systematic analysis of the medical literature from peer reviewed journals. Established methodology principles such as Grading of Recommendations Assessment, Development, and Evaluation or GRADE are adapted to evaluate the evidence. The RAND/UCLA Appropriateness Method User Manual provides the methodology to determine the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where peer reviewed literature is lacking or equivocal, experts may be the primary evidentiary source available to formulate a recommendation.
| Original language | English (US) |
|---|---|
| Pages (from-to) | S310-S325 |
| Journal | Journal of the American College of Radiology |
| Volume | 21 |
| Issue number | 6 |
| DOIs | |
| State | Published - Jun 2024 |
Funding
Dr Bardo reports leadership roles as Ann & Robert H Lurie Children's Hospital of Chicago - Vice Chair of Medical Imagining and Faculty in the Center for Quality and Safety, ISMRM -Pediatric Study Group Vice Chair. Dr Chan reports patents from Patent on machine learning for vascular ultrasound. Dr Guimaraes reports leadership roles as Board of Directors ASPNR, Chief of Pediatric radiology UNC, Nominating Committee SPR. Dr Liang reports support for meetings from Boston Children's Hospital; leadership roles as Vascular Anomalies Center, Boston Children's Hospital. Dr Pruthi reports participation on an advisory board for SECTRA advisory board but no financial benefits or relationship. Dr Sammer reports leadership roles as ACR Pediatric AI Workgroup Chair, ACR Pediatric Quality & Safety Committee Chair - no financial renumeration. Dr Schooler reports grants or contracts from COG/NCI funding for radiomics in hepatoblastoma from AHEP0731; leadership roles as Associate Division Director of Pediatric Radiology (UTSW), Chair - Abdominal Imaging Committee, Society for Pediatric Radiology, Chair-ACR Pediatric LIRADS Working Group. Dr Trout reports grants or contracts from GE Healthcare, Siemens Healthineers, Perspectum Inc; consulting fees from GE Healthcare; support for meetings from Philips Healthcare; leadership roles as JRCNMT \u2013 Chair, Director of Clinical Research for Radiology - Cincinnati Children's. Dr Cooper is a partner; and the other authors are non-partner/non-partnership track/employees.
Keywords
- AUC
- Appropriateness Criteria
- appropriate use criteria
- infantile hemangioma
- lymphatic malformation
- vascular anomaly
- vascular malformation
- vascular tumor
- venous malformation
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging